
Profound Medical Corp
TSX:PRN

Intrinsic Value
The intrinsic value of one
PRN
stock under the Base Case scenario is
7.84
CAD.
Compared to the current market price of 8.68 CAD,
Profound Medical Corp
is
Overvalued by 10%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Profound Medical Corp
Fundamental Analysis


Revenue & Expenses Breakdown
Profound Medical Corp
Balance Sheet Decomposition
Profound Medical Corp
Current Assets | 69.1m |
Cash & Short-Term Investments | 54.9m |
Receivables | 7m |
Other Current Assets | 7.1m |
Non-Current Assets | 1.2m |
PP&E | 821k |
Intangibles | 261k |
Other Non-Current Assets | 87k |
Free Cash Flow Analysis
Profound Medical Corp
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Profound Medical Corp
Revenue
|
10.7m
USD
|
Cost of Revenue
|
-3.6m
USD
|
Gross Profit
|
7m
USD
|
Operating Expenses
|
-40.1m
USD
|
Operating Income
|
-33.1m
USD
|
Other Expenses
|
5.2m
USD
|
Net Income
|
-27.8m
USD
|
PRN Profitability Score
Profitability Due Diligence
Profound Medical Corp's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

Score
Profound Medical Corp's profitability score is 26/100. The higher the profitability score, the more profitable the company is.
PRN Solvency Score
Solvency Due Diligence
Profound Medical Corp's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

Score
Profound Medical Corp's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
PRN Price Targets Summary
Profound Medical Corp
According to Wall Street analysts, the average 1-year price target for
PRN
is 24.91 CAD
with a low forecast of 24.66 CAD and a high forecast of 25.64 CAD.
Dividends
Current shareholder yield for PRN is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
PRN
stock under the Base Case scenario is
7.84
CAD.
Compared to the current market price of 8.68 CAD,
Profound Medical Corp
is
Overvalued by 10%.